Market Overview

UPDATE: Deutsche Bank Cuts PT to $68 on Humana on Senior Management Turnover

Related HUM
Barclays On Humana: 'Stronger Core Ops Should Offset Potential '18 MA Star Headwind'
Earnings Season On Deck: How Has Q3 Guidance Looked So Far?
Anthem, Part 2 - Why You Shouldn't Buy This Great Health Stock Now (Seeking Alpha)

Deutsche Bank maintained Humana (NYSE: HUM) with a Hold and lowers the price target from $80.00 to $68.00.

Deutsche Bank noted, "The turnover of Humana's senior management team continues to play out as CFO Jim Bloem announced that he will retire at the end of the 2013. This follows the retirement of former CEO Mike McCallister at the end of 2012. Mr. Bloem captured the entire upcycle in MA during his tenure as CFO and now could be exiting right in front of a potential MA downturn that could begin in 2014 based on the highly challenging prelim 2014 MA rate proposal. We continue to see elevated EPS headwinds for the MCO industry in 2014 and reduce our PT for HUM to $68 from $80."

Humana closed at $69.66 on Monday.

Latest Ratings for HUM

Sep 2016Evercore ISI GroupInitiates Coverage onBuy
Aug 2016Credit SuisseMaintainsNeutral
Aug 2016BarclaysMaintainsEqual-Weight

View More Analyst Ratings for HUM
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Price Target Analyst Ratings


Related Articles (HUM)

View Comments and Join the Discussion!